Back to User profile » Dr Nan Li
Papers published by Dr Nan Li:
Utility of Novel Lipid Parameters for Risk Stratification in Patients with Diabetes and STEMI–from a Prospective Study
Zhao X, Chen R, Li J, Zhou J, Li N, Xue L, Yan S, Liu C, Zhou P, Chen Y, Song L, Zhao H, Yan H
Vascular Health and Risk Management 2026, 22:560787
Published Date: 30 January 2026
Elevated Circulating Adipocyte-Fatty Acid Binding Protein Levels Predict Incident Ischemic Cardiovascular Events in a Longitudinal and Prospective AMI Aging Study
Zhao X, Zhao H, Chen R, Zhou J, Li N, Li J, Yan S, Liu C, Zhou P, Chen Y, Song L, Yan H
Journal of Inflammation Research 2025, 18:1589-1608
Published Date: 4 February 2025
A Combined Measure of the Triglyceride Glucose Index and Trimethylamine N-Oxide in Risk Stratification of ST-Segment Elevation Myocardial Infarction Patients with High-Risk Plaque Features Defined by Optical Coherence Tomography: A Substudy of the OCTAMI Registry Study
Zhao X, Zhao H, Chen R, Li J, Zhou J, Li N, Yan S, Liu C, Zhou P, Chen Y, Song L, Yan H
Vascular Health and Risk Management 2024, 20:141-155
Published Date: 29 March 2024
Associations Between Resolvin D1 and Culprit Plaque Morphologies: An Optical Coherence Tomography Study in Patients with ST-Segment Elevation Myocardial Infarction
Chen R, Li J, Sheng Z, Zhou J, Wang Y, Zhao X, Li N, Liu W, Liu C, Zhou P, Chen Y, Yan S, Song L, Yan H, Zhao H
Journal of Inflammation Research 2023, 16:6457-6467
Published Date: 28 December 2023
Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort Study
Zhao X, Song L, Li J, Zhou J, Li N, Yan S, Chen R, Wang Y, Liu C, Zhou P, Sheng Z, Chen Y, Zhao H, Yan H
Journal of Inflammation Research 2023, 16:269-282
Published Date: 21 January 2023